Autonomix Medical宣布论文摘要获2026消化疾病周接受 展示胰腺癌疼痛管理的长期数据

美股速递
Apr 29

Autonomix Medical Inc (股票代码: AMIX) 宣布,其关于胰腺癌疼痛管理的长期数据研究摘要,已被2026年消化疾病周(DDW)学术会议正式接收。

这项突破性研究将重点展示该公司创新疗法在缓解胰腺癌相关疼痛方面的持久疗效。消化疾病周作为国际消化系统疾病领域的顶级学术盛会,此次摘要入选标志着专业界对该项临床数据科学价值的高度认可。

长期随访数据的披露,将为医疗界提供关于神经调控技术治疗癌性疼痛的新证据。该研究成果的呈现,有望推动胰腺癌综合治疗方案的优化进程。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10